Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 130,089 | 65,676 | 0 | N/A | N/A |
| TOTAL | $133,045 | $65,998 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 42 | 25 | 0 | N/A | N/A |
| Other Non-Current Assets | 522 | 0 | 0 | 0 | 0 |
| TOTAL | $563 | $25 | $N/A | $N/A | $N/A |
| Total Assets | $133,608 | $66,023 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,177 | 1,739 | 0 | 0 | 0 |
| Accrued Expenses | 6,643 | 3,129 | 0 | N/A | N/A |
| TOTAL | $9,062 | $4,868 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 303 | 0 | 0 | 0 | 0 |
| TOTAL | $303 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,364 | $4,868 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053 | N/A | N/A | N/A | N/A |
| Common Shares | 21 | 127 | 0 | N/A | N/A |
| Retained earnings | -90,528 | -62,469 | 0 | N/A | N/A |
| Other shareholders' equity | -11,534 | 103,829 | 0 | 0 | 0 |
| TOTAL | $124,244 | $61,155 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $133,608 | $66,023 | $0 | $0 | $0 |